Cancer risk reduction

If only we lived in a perfect world, where all we have to do is get our nutrients from food...

In life and diets: nothing is perfect

By Judy Blatman, Senior Vice President, Communications, Council for Responsible Nutrition

If only I lived in a perfect world, like, say, Dr. Edgar Miller, one of the five doctors who have determined from on high via their editorial in the Annals of Internal Medicine, that no one needs to take a multivitamin.

One vitamin to rule them all? Gollum’s D deficiency dilemma

By Shane STARLING

It wasn’t just crafty hobbits that enabled the dark forces of Middle Earth to be defeated in science fantasy godfather JRR Tolkien’s Lord of the Rings – they were also vitamin D deficient, scientists have discovered.

Review questions vitamin D for reducing chronic disease risk

Review questions vitamin D for reducing chronic disease risk

By Stephen DANIELLS

Low vitamin D levels may be a consequence of ill health and not the cause of chronic disease, says a new review, but industry groups have responded that supplementation is vital for bone health and should not be dismissed.

Probiota 2012 probiotic conference extends poster deadline

Poster deadline extended by one week to December 13

Probiota 2014: Poster proposal deadline extended

By Nathan Gray

Probiota 2014 – the leading conference bridging the interface of academia and industry for cutting edge science about the prebiotics, probiotics and the microbiome – has extended the call for proposals for its poster sessions by one week to Friday 13th...

Probiota 2014 Poster Sessions will add even more cutting edge science to the program. Will you be there to present your findings?

Probiota 2014, February 4-5, Amsterdam, the Netherlands

Probiota 2014 calls for cutting edge science for inaugural Poster Sessions

By Nathan Gray

Probiota 2014 – the leading conference bridging the interface of academia and industry for cutting edge science about the prebiotics, probiotics and the microbiome – is calling for proposals for its poster sessions to showcase the latest research and...

Steve Mister, president and CEO of CRN.

Guest Commentary

A Whale of a Fish Story for Omega-3s

By Steve Mister

There’s something fishy going on with omega-3s these days, and it appears that some of the consumer media who reported on the study fell for it – hook, line and sinker. Of course I’m talking about the study that recently published in the Journal of the...

Blue lupin kernel fiber may boost colon health: RCT

Blue lupin kernel fiber may boost colon health: RCT

By Stephen DANIELLS

Fibers from the blue lupin kernel may improve the function of the colon and potential reduce the risk of colon cancer, says a new study from Friedrich Schiller University of Jena in Germany.

Not just industry slamming omega-3-prostate cancer links

Not just industry slamming omega-3-prostate cancer links

By Alan Ruth, PhD

Reaction to last week’s study linking omega-3 with prostate cancer have been vociferous and near-unanimous in condemning its methods and conclusions. Here Alan Ruth, PhD, and CEO of the Irish Health Trade Association (IHTA), explains why that condemnation...

There’s no such thing as a ‘miracle food’ warn experts

There’s no such thing as a ‘miracle food’ warn experts

By Nathan Gray

Researchers and global media should better consider the validity of single scientific studies that report on supposed ‘miracle foods’ in addition to considering that people do not eat foods or nutrients in isolation, warn researchers.

Red revolution: As science grows for lycopene, will the market follow?

Special edition: Antioxidants and Carotenoids

A red revolution: As the science grows for lycopene, will the market follow?

By Nathan Gray

Lycopene has a growing reputation among the carotenoids, but have we started to see a red revolution in the market? In this special edition article, NutrIngredients asks where the science and the market data stand on the tomato compound.

AHP moves ahead with cannabis monograph

AHP moves ahead with cannabis monograph

By Hank Schultz

As questions swirl around the nutraceutical potential of cannabis products (and their regulatory status), the American Herbal Pharmacopoeia is moving ahead with the production of a cannabis monograph with support from a nascent cannabis company.